21310708|t|Safety and tolerability of galantamine SA in dementia patients transitioned from donepezil.
21310708|a|OBJECTIVE: To demonstrate the safety and tolerability of galantamine SA in dementia patients transitioned from donepezil. DESIGN: One group, pretest-posttest SETTING: Veterans Affairs (VA) hospital serving U.S. veterans. PATIENTS, PARTICIPANTS: Charts of 193 patients changed from donepezil to galantamine SA were reviewed. INTERVENTION: In an effort to limit the cost of medications being used for Alzheimer's disease, the Bedford VA Hospital began an initiative to transition patients to the generic sustained-release galantamine SA. A chart review was performed using the VA computerized patient record for all patients transitioned from either donepezil or rivastigmine to galantamine. Progress notes were reviewed for the first three months following initial medication exchange to determine galantamine tolerability and reasons for discontinuation. MAIN OUTCOME MEASURE: Galantamine SA tolerability at three months. RESULTS: Of the 193 patients transitioned to galantamine SA, 94.3% remained on the drug at three months. The most common reason for medication withdrawal was mental status change (n = 5). CONCLUSION: Transition to galantamine SA in a real world clinical setting was well-tolerated among patients with dementia.
21310708	27	41	galantamine SA	Chemical	-
21310708	45	53	dementia	Disease	MESH:D003704
21310708	54	62	patients	Species	9606
21310708	81	90	donepezil	Chemical	MESH:D000077265
21310708	149	163	galantamine SA	Chemical	-
21310708	167	175	dementia	Disease	MESH:D003704
21310708	176	184	patients	Species	9606
21310708	203	212	donepezil	Chemical	MESH:D000077265
21310708	313	321	PATIENTS	Species	9606
21310708	351	359	patients	Species	9606
21310708	373	382	donepezil	Chemical	MESH:D000077265
21310708	386	400	galantamine SA	Chemical	-
21310708	491	510	Alzheimer's disease	Disease	MESH:D000544
21310708	570	578	patients	Species	9606
21310708	612	626	galantamine SA	Chemical	-
21310708	683	690	patient	Species	9606
21310708	706	714	patients	Species	9606
21310708	740	749	donepezil	Chemical	MESH:D000077265
21310708	753	765	rivastigmine	Chemical	MESH:D000068836
21310708	769	780	galantamine	Chemical	MESH:D005702
21310708	889	900	galantamine	Chemical	MESH:D005702
21310708	969	983	Galantamine SA	Chemical	-
21310708	1034	1042	patients	Species	9606
21310708	1059	1073	galantamine SA	Chemical	-
21310708	1228	1242	galantamine SA	Chemical	-
21310708	1301	1309	patients	Species	9606
21310708	1315	1323	dementia	Disease	MESH:D003704
21310708	Comparison	MESH:D000068836	MESH:D005702
21310708	Negative_Correlation	MESH:D000077265	MESH:D003704
21310708	Comparison	MESH:D000077265	MESH:D005702

